The company does not own manufacturing facilities for EGRIFTA SV®, tesamorelin, sudocetaxel zendusortide, or Trogarzo® and relies on third-party contract manufacturing organizations. Bachem and Jubilant manufacture and supply raw materials, drug substance, and drug product for EGRIFTA SV®. Bachem is the sole approved manufacturer of the active pharmaceutical ingredient (API) for tesamorelin and the F8 Formulation. Jubilant supplies the finished form of EGRIFTA SV® for commercial sale and clinical trials. LSNE is contracted for manufacturing and commercial supply of the F8 Formulation, if approved. Packaging of administration boxes for EGRIFTA SV® is performed by Sharp Packaging Services, LLC, and will be handled by Almac Pharma Services LLC for the F8 Formulation, if approved. TaiMed is the sole supplier of Trogarzo®, subcontracting its manufacture to WuXi in China and Samsung in South Korea. STA Pharmaceutical Hong Kong Limited manufactures the peptide TH19P01 and produces sudocetaxel zendusortide. Piramal Pharma Solutions, Inc. manufactures the finished form of sudocetaxel zendusortide, which is then labeled and packaged by Sharp Clinical Services, LLC for clinical trials.
Theratechnologies Inc's Comment on Supply Chain
The company does not own manufacturing facilities for EGRIFTA SV®, tesamorelin, sudocetaxel zendusortide, or Trogarzo® and relies on third-party contract manufacturing organizations. Bachem and Jubilant manufacture and supply raw materials, drug substance, and drug product for EGRIFTA SV®. Bachem is the sole approved manufacturer of the active pharmaceutical ingredient (API) for tesamorelin and the F8 Formulation. Jubilant supplies the finished form of EGRIFTA SV® for commercial sale and clinical trials. LSNE is contracted for manufacturing and commercial supply of the F8 Formulation, if approved. Packaging of administration boxes for EGRIFTA SV® is performed by Sharp Packaging Services, LLC, and will be handled by Almac Pharma Services LLC for the F8 Formulation, if approved. TaiMed is the sole supplier of Trogarzo®, subcontracting its manufacture to WuXi in China and Samsung in South Korea. STA Pharmaceutical Hong Kong Limited manufactures the peptide TH19P01 and produces sudocetaxel zendusortide. Piramal Pharma Solutions, Inc. manufactures the finished form of sudocetaxel zendusortide, which is then labeled and packaged by Sharp Clinical Services, LLC for clinical trials.
Sources:
Theratechnologies Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Theratechnologies Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
